Postprandial hyperglycemia is highly prevalent throughout the day in type 2 diabetes patients

Diabetes Research and Clinical Practice

Volumn 93, Issue 1, 2011, Pages 31-37

  van Dijk, Jan Willem ^a   Manders, Ralph J F ^a   Hartgens, Fred ^a   Stehouwer, Coen D ^b   Praet, Stephan F E ^c   van Loon, Luc J C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Continuous glucose monitoring; Glycemic control; Normal glucose tolerance; Postprandial hyperglycemia; Type 2 diabetes mellitus

Indexed keywords

GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC DIET; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION; PHYSICAL ACTIVITY; POSTPRANDIAL HYPERGLYCEMIA; POSTPRANDIAL STATE; PREVALENCE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED;

EID: 79960563297     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.03.021     Document Type: Article

References (28)

1. Cavalot F., Petrelli A., Traversa M., Bonomo K., Fiora E., Conti M., et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006, 913:813-819.
2. de Vegt F., Dekker J.M., Ruhe H.G., Stehouwer C.D., Nijpels G., Bouter L.M., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999, 428:926-931.
3. Meigs J.B., Nathan D.M., D'Agostino R.B., Wilson P.W. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 2510:1845-1850.
4. Woerle H.J., Pimenta W.P., Meyer C., Gosmanov N.R., Szoke E., Szombathy T., et al. Diagnostic and therapeutic implications of relationships between fasting, 2-h postchallenge plasma glucose and hemoglobin A1c values. Arch Intern Med 2004, 16415:1627-1632.
5. Monnier L., Lapinski H., Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003, 263:881-885.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 4146865:813-820.
7. Ceriello A., Esposito K., Piconi L., Ihnat M.A., Thorpe J.E., Testa R., et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 575:1349-1354.
8. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 29514:1681-1687.
9. ADA Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl 1):S11-S61.
10. Ceriello A., Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet Med 2008, 2510:1151-1156.
11. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009, 521:17-30.
12. Boland E., Monsod T., Delucia M., Brandt C.A., Fernando S., Tamborlane W.V. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001, 2411:1858-1862.
13. Praet S.F., Manders R.J., Meex R.C., Lieverse A.G., Stehouwer C.D., Kuipers H., et al. Glycaemic instability is an underestimated problem in type II diabetes. Clin Sci (Lond) 2006, 1112:119-126.
14. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 2112:2191-2192.
15. Mari A., Pacini G., Murphy E., Ludvik B., Nolan J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001, 243:539-548.
16. Maran A., Crepaldi C., Tiengo A., Grassi G., Vitali E., Pagano G., et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002, 252:347-352.
17. Wentholt I.M., Vollebregt M.A., Hart A.A., Hoekstra J.B., DeVries J.H. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care 2005, 2812:2871-2876.
18. Maran A., Crepaldi C., Avogaro A., Catuogno S., Burlina A., Poscia A., et al. Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev 2004, 20(Suppl 2):S50-S55.
19. Bantle J.P., Wylie-Rosett J., Albright A.L., Apovian C.M., Clark N.G., Franz M.J., et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl 1):S61-78.
20. Monnier L., Colette C., Dunseath G.J., Owens D.R. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007, 302:263-269.
21. Monnier L., Colette C., Rabasa-Lhoret R., Lapinski H., Caubel C., Avignon A., et al. Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 2002, 254:737-741.
22. Boden G., Chen X., Urbain J.L. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 1996, 458:1044-1050.
23. Radziuk J., Pye S. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?. Diabetologia 2006, 497:1619-1628.
24. Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration?. Diabetologia 2009, 527:1219-1226.
25. Manders R.J., Praet S.F., Meex R.C., Koopman R., de Roos A.L., Wagenmakers A.J., et al. Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients. Diabetes Care 2006, 2912:2721-2722.
26. Pearce K.L., Noakes M., Keogh J., Clifton P.M. Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes. Am J Clin Nutr 2008, 873:638-644.
27. Manders R.J., Van Dijk J.W., van Loon L.J. Low-intensity exercise reduces the prevalence of hyperglycemia in type 2 diabetes. Med Sci Sports Exerc 2010, 422:219-225.
28. Praet S.F., Manders R.J., Lieverse A.G., Kuipers H., Stehouwer C.D., Keizer H.A., et al. Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes. Med Sci Sports Exerc 2006, 3812:2037-2044.